Kanzhun Limited BZ
17.12 USD +0.06 (+0.35%)
At closeNov 3, 2026, 4:08 PM EST
17.25 +0.13 +0.76%
After hours · Nov 3, 4:08 PM ET
16.95 Day range 17.26
12.57 52-week range 22.49
- YTD
- -16.00%
- 1 year
- -24.25%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 21.81 +27.4% upside
Now 17.12
- Target (low)
- 17.13
- Target (mean)
- 21.81
- Target (high)
- 27.22
Ratings (0m) 23 21 buy · 2 hold · 0 sell
- Strong buy5
- Buy16
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 23
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.26 | 2.15 – 2.40 | 2.16 | +4.8% | 2.47B | +14.3% | 8 |
| Next quarter | 2.23 | 2.11 – 2.34 | 1.90 | +17.5% | 2.36B | +13.4% | 7 |
| Current year | 8.59 | 8.31 – 8.87 | 7.87 | +9.1% | 9.29B | +12.4% | 14 |
| Next year | 9.95 | 8.74 – 10.68 | 8.59 | +15.9% | 10.47B | +12.6% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2026 | Barclays | Maintained | Overweight | Overweight |
| Aug 18, 2026 | B of A Securities | Initiated | — | Neutral |
| Jun 5, 2026 | Bernstein | Upgrade | Market Perform | Outperform |
| Mar 20, 2026 | Barclays | Maintained | Overweight | Overweight |
| Nov 19, 2025 | Barclays | Maintained | Overweight | Overweight |
| Aug 22, 2025 | Barclays | Maintained | Overweight | Overweight |
| Aug 21, 2025 | UBS | Upgrade | Neutral | Buy |
| Aug 20, 2025 | Jefferies | Maintained | Buy | Buy |
| Mar 13, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 9, 2024 | Barclays | Maintained | Overweight | Overweight |
| Dec 9, 2024 | Bernstein | Downgrade | Outperform | Market Perform |
| Nov 29, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 30, 2024 | Barclays | Maintained | Overweight | Overweight |
| May 22, 2024 | UBS | Maintained | Neutral | Neutral |
| May 22, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 13, 2024 | Barclays | Maintained | Overweight | Overweight |
| Mar 13, 2024 | New Street Research | Upgrade | Neutral | Buy |
| Mar 12, 2024 | Macquarie | Upgrade | Neutral | Outperform |
| Dec 20, 2023 | New Street Research | Initiated | — | Neutral |
| Dec 13, 2023 | JP Morgan | Initiated | — | Overweight |
| Sep 1, 2023 | UBS | Downgrade | Buy | Neutral |
| Aug 31, 2023 | Barclays | Maintained | Overweight | Overweight |
| Aug 30, 2023 | Bernstein | Maintained | Outperform | Outperform |
| Aug 22, 2023 | Macquarie | Downgrade | Outperform | Neutral |
| Aug 21, 2023 | Macquarie | Downgrade | Outperform | Neutral |
| Jul 20, 2023 | Citigroup | Initiated | — | Buy |
| May 3, 2023 | Macquarie | Initiated | — | Outperform |
| Mar 29, 2023 | Barclays | Maintained | — | Equal-Weight |
| Nov 14, 2022 | Goldman Sachs | Upgrade | Neutral | Buy |
| Oct 28, 2022 | Barclays | Maintained | — | Equal-Weight |
